Experts Share Top Highlights from the 2024 SGO Annual Meeting on Women’s Cancer
Dr Marth on Frontline Lenvatinib Plus Pembrolizumab in Endometrial Cancer
Dr Mirza on the Findings From Part 2 of the RUBY Trial in Endometrial Cancer
Mahtani Emphasizes Empowering Women in Oncology Through Sponsorship, Support Networks, and Self Care